Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 4, 2023
- Accession no.
- 0001415889-23-011859
- Filed
- Aug 4, 2023
- Trade date
- Aug 3, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.42M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Common Stock | MOption exerciseAcquired | +6,000 | $117.76 | +$706,560 | 42,599 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −1,259 | $232.96F2 | −$293,296.64 | 41,340 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −2,141 | $233.53F3 | −$499,987.73 | 39,199 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −600 | $236.88F4 | −$142,128 | 38,599 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −300 | $238.39F5 | −$71,517 | 38,299 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −400 | $239.99F6 | −$95,996 | 37,899 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −1,000 | $241.61F7 | −$241,610 | 36,899 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −300 | $243.13F8 | −$72,939 | 36,599 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 144,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $232.22 to $233.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $233.22 to $234.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $236.50 to $237.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $238.10 to $238.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $239.94 to $240.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $241.40 to $241.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $242.57 to $243.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.